Karin Roberg

Karin Roberg is a Visiting Professor at Linköping University, affiliated with the Department of Biomedical and Clinical Sciences (BKV) and the Division of Cell and Neurobiology (CNB). Her primary focus is improving treatment outcomes for head and neck cancer patients through personalized medicine. She investigates predictive biomarkers and treatment resistance mechanisms in head and neck squamous cell carcinomas (HNSCC), aiming to reduce patient suffering and healthcare costs.

Her research emphasizes signaling pathways involved in resistance to cisplatin, cetuximab, and radiotherapy. Collaborations involve tumor biopsies, patient-derived cell lines, and xenograft models to identify therapeutic targets. Key areas include biomarker discovery for treatment response prediction and development of novel therapies.

Recent studies include a pilot project on early mortality prediction in head and neck cancer and investigations into tumor-associated fibroblast effects on cancer cell behavior. She also contributed to methodological advancements in laser Doppler flowmetry for microcirculation analysis.

Labs/Teams: Active within the Division of Cell and Neurobiology and the Department of Biomedical and Clinical Sciences at Linköping University. Research integrates clinical, cellular, and molecular approaches to address unmet needs in oncology.